The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Current status of physicians’ perception of HCC conversion/downstaging therapy: A nationwide survey in China.
 
Xinyu Bi
No Relationships to Disclose
 
Xiao Liang
No Relationships to Disclose
 
Guang Tan
No Relationships to Disclose
 
Haitao Zhao
No Relationships to Disclose
 
Tao Huang
No Relationships to Disclose
 
Ming Zhao
No Relationships to Disclose
 
Jinzhang Chen
No Relationships to Disclose
 
Xiao-Dong Zhu
No Relationships to Disclose
 
Jianfeng Xue
No Relationships to Disclose
 
Hui-Chuan Sun
Employment - Zhongshan Hospital, Fudan University
Honoraria - AstraZeneca; Bayer; BeiGene; Eisai; Hengrui Pharmaceutical; Innovent Biologics; MSD; Roche; TopAlliance BioSciences Inc; Zelgen
Research Funding - Innovent Biologics (Inst); MSD (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Radiomic features to predict tumor response to systemic therapy in liver cancer patients (Inst)
 
Jianqiang Cai
No Relationships to Disclose
 
China Liver Cancer Study Group Young Investigators (CLEAP)
No Relationships to Disclose